YANA DUDKO: Open Payments
NPI 1427405372 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,887 in 77 payments from 16 companies in 2025. Trend: 2023 $1,474 · 2024 $1,694 · 2025 $1,887
Food & beverage: $1,887
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $263 |
| SCPHARMACEUTICALS INC. | 7 | $262 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $229 |
| Otsuka America Pharmaceutical, Inc. | 4 | $201 |
| Mallinckrodt Hospital Products Inc. | 9 | $199 |
| Travere Therapeutics, Inc. | 7 | $128 |
| OPKO Pharmaceuticals, LLC | 6 | $117 |
| AstraZeneca Pharmaceuticals LP | 6 | $113 |
| Calliditas Therapeutics US Inc. | 2 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
Products named: FUROSCIX, JARDIANCE, KRYSTEXXA, JYNARQUE, ACTHAR, RAYALDEE, FARXIGA, TARPEYO.
Industry payments across TX — which companies pay providers there.
